SuperworthVoyager Therapeutics market cap VYGR
Share price times shares outstanding: what the whole company sells for, since 2015.
- Today, Oct 23, 2026
- $107.2M
- Highest close in our data
- $1B
- Jun 2019
Voyager Therapeutics is worth $107.2M at the close on Oct 23, 2026, at $1.74 a share.
That is down 58% over the last year and down 22% over five years.
Its highest close in our data was $1B in Jun 2019.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $107.2M | $107.2M | $265.8M | −53% |
| 2025 | $226.8M | $151.6M | $329.9M | −28% |
| 2024 | $313.6M | $308.1M | $512.6M | −16% |
| 2023 | $371.3M | $268.7M | $573.4M | +58% |
| 2022 | $235.5M | $106.3M | $359.8M | +129% |
| 2021 | $102.9M | $99M | $338.7M | −62% |
| 2020 | $267.9M | $256.4M | $533.9M | −48% |
| 2019 | $516.8M | $268.9M | $1B | +74% |
| 2018 | $296.9M | $284.2M | $810.9M | −34% |
| 2017 | $447.4M | $229.8M | $621.5M | +31% |
| 2016 | $340.4M | $233.8M | $503.7M | −42% |
| 2015 | $585.8M | $560.7M | $585.8M | n/a |
Against its peers
Companies in Healthcare nearest Voyager Therapeutics' size, closest first, today.
| Company | Market cap |
|---|---|
| VYGRVoyager Therapeutics | $107.2M |
| KEQUKewaunee Scientific | $94.9M |
| ICCCImmucell | $93.1M |
| LFVNLifevantage | $73.4M |
| SPROSpero Therapeutics | $64.6M |
| PDEXPro DEX | $199.3M |
| APTAlpha Pro Tech | $56.7M |
| PLXProtalix BioTherapeutics | $205.5M |
| NATRNatures Sunshine Products | $213.8M |
| ELMDElectromed | $220.6M |
| UTMDUtah Medical Products | $236.3M |
| Peer median | $147.1M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Voyager Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.